clinical development

Izaak den Daas Speaks at the 16th Annual Early Clinical Development: Phase I & IIa Symposium in London

Topic: incorporating healthy volunteers and academic hospital collaborations to optimize early clinical drug development

The focus of the 2015 Early Clinical Development: Phase I & IIa Symposium is how to accelerate the route to proof of concept by using effective strategies, innovative platforms and collaboration with industry professionals. To this end, on the first day of the conference, QPS Principal Scientist & Manager Medical Operations Izaak den Daas will present on incorporating healthy volunteers and academic hospital collaborations to optimize early clinical drug development. During the talk, den Daas will cover QPS’ strategy for working with academic hospitals and use case studies in CNS research to explore effective strategies for early phase trials. The talk will end with a summary of lessons learned, and key take home messages.

Where and when:
Early Clinical Development: Phase I &IIa Symposium
Park Plaza Victoria, London, UK
Day One - Industry Challenges and Trends
Tuesday 24 February 2015
Stream One: Accelerating Early Clinical Research
16:00 (just following afternoon tea)

back
top
20 years in pharma R&D navigation